Jeroen Jansen PhD

Jeroen Jansen, Ph.D. is a methodologist working at the intersection of evidence synthesis, biostatistics, and health economics. He has extensive research and management experience. Jeroen is an Associate Professor in the Department of Clinical Pharmacy in the School of Pharmacy at the University of California, San Francisco. He also acts as Chief Scientist - Health Economics & Outcomes Research (HEOR) at the Precision Medicine Group.

For the past 20 years, Jeroen has worked on research and projects to understand the clinical and economic value of healthcare interventions. His research has frequently been conducted in the context of health technology assessment (HTA) with a focus on comparative effectiveness and cost-effectiveness. Prompted by the challenges encountered in applied research projects, he has performed methodological research. His current academic research interests are the clinical and economic value of precision medicine, modeling the health inequality impact of new health technologies, and statistical methods for evidence synthesis.

Jeroen has published extensively in his areas of expertise and is widely cited. He is a co-author of a textbook on network meta-analysis for decision-making. He has a PhD in epidemiology from the Erasmus University in the Netherlands. Jeroen managed research teams in private research companies that provided HEOR services to the life sciences industry for over 10 years and was the founder of a successful business.